Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bartosz Szostak, Filip Machaj, Jakub Rosik & Andrzej Pawlik. (2019) Umbilical cord blood transplantation and the impact of the CTLA4 genotype on outcomes. Expert Review of Hematology 12:12, pages 1089-1094.
Read now
Read now
Articles from other publishers (7)
Jakub Rosik, Bartosz Szostak, Filip Machaj & Andrzej Pawlik. (2021) The Role of CTLA4 and Its Polymorphisms in Solid Organ and Haematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences 22:6, pages 3081.
Crossref
Crossref
Jacobo Trebol Lopez, Tihomir Georgiev-Hristov, Mariano García-Arranz & Damián García-Olmo. 2013. Regenerative Medicine and Cell Therapy. Regenerative Medicine and Cell Therapy
245
277
.
Jacobo Trebol LopezTihomir Georgiev HristovMariano García-ArranzDamián García-Olmo. (2011) Stem Cell Therapy for Digestive Tract Diseases: Current State and Future Perspectives. Stem Cells and Development 20:7, pages 1113-1129.
Crossref
Crossref
Toshihisa Tsuruta, Yasuo Aihara, Hitoshi Kanno, Chikako Kiyotani, Katsuya Maebayashi, Masako Sakauchi, Makiko Osawa, Hisaichi Fujii, Osami Kubo & Yoshikazu Okada. (2011) High-dose chemotherapy followed by autologous and allogeneic peripheral blood stem cell transplantation for recurrent disseminated trilateral retinoblastoma. Child's Nervous System 27:6, pages 1019-1024.
Crossref
Crossref
Olle Ringdén, Helen Karlsson, Richard Olsson, Brigitta Omazic & Michael Uhlin. (2009)
The allogeneic graft‐
versus
‐cancer effect
. British Journal of Haematology 147:5, pages 614-633.
Crossref
Crossref
Teresa Ramirez-Montagut, Andrew Chow, Adam A. Kochman, Odette M. Smith, David Suh, Hamad Sindhi, Sydney Lu, Chiara Borsotti, Jeremy Grubin, Neel Patel, Theis H. Terwey, Theo D. Kim, Glenn Heller, George F. Murphy, Chen Liu, Onder Alpdogan & Marcel R. M. van den Brink. (2007) IFN-γ and Fas Ligand Are Required for Graft-versus-Tumor Activity against Renal Cell Carcinoma in the Absence of Lethal Graft-versus-Host Disease. The Journal of Immunology 179:3, pages 1669-1680.
Crossref
Crossref
Akihiko Numata, Keiko Yasuda, Takahiro Fukuda, Eishi Baba, Satoshi Yamasaki, Ken Takase, Toshihiro Miyamoto, Koji Nagafuji, Shuji Nakano & Mine Harada. (2005) Non-myeloablative allogeneic haemopoietic stem-cell transplantation for treatment of metastatic invasive thymoma. The Lancet Oncology 6:8, pages 626-628.
Crossref
Crossref